Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: Studies by gene disruption and antisense mRNA inhibition

BMC Molecular Biology

Volumn 6, Issue , 2005, Pages

  Mundodi, Vasanthakrishna ^a   Kucknoor, Ashwini S ^a   Gedamu, Lashitew ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYSTEINE PROTEINASE; MESSENGER RNA; LDCCYS2 PROTEIN, LEISHMANIA CHAGASI; PROTEIN; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN;

AMASTIGOTE; ARTICLE; CONTROLLED STUDY; ENZYME SPECIFICITY; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE SILENCING; GENETIC ORGANIZATION; HETEROZYGOSITY; HOMOLOGOUS RECOMBINATION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; NONHUMAN; NORTHERN BLOTTING; PARASITE SURVIVAL; PATHOGENESIS; PROTEIN EXPRESSION; SOUTHERN BLOTTING; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL STRAIN U937; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENE; GENE EXPRESSION; GENETICS; LEISHMANIA INFANTUM; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PARASITOLOGY; PHYSIOLOGY; SURVIVAL;

LEISHMANIA DONOVANI; LEISHMANIA DONOVANI CHAGASI; PROTOZOA;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; GENES, PROTOZOAN; HUMANS; LEISHMANIA INFANTUM; MACROPHAGES; PROTEINS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; RNA, ANTISENSE; RNA, MESSENGER; SURVIVAL; U937 CELLS;

EID: 26444530670     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-6-3     Document Type: Article

References (33)

1. Badaro R, Jones TC, Lorenzo R: A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986, 154:639-649.
2. Evans TG, Teixeira MJ, McAuliffe IT: Epidemology of visceral leishmaniasis in Northeast Brazil. J Infect Dis 1992, 166:1124-1132.
3. Tselentis Y, Gilkas A, Chaniotis B: Kala-azar in Athens basin. Lancet 1994:1635.
4. Mottram JC, Brooks DR, Coombs GH: Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1998, 1:445-460.
5. Mottram JC, Coombs GH, Alexander J: Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 2004, 7:375-381.
6. Mayer R, Picard I, Lawton P, Grellier P, Barrault C, Monsigny M, Schrevel J: Peptide derivatives specific for a Plasmodium falciparum proteinase inhibit the erythrocyte invasion by merozoites. J Med Chem 1991, 34:3029-3035.
7. Que X, Reed SL: Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000, 13:196-206.
8. Coombs GH, Baxter J: Inihibition of Leishmania amastigote growth by antipain and leupeptin. Ann Trop Med Parasitol 1984, 78:21-24.
9. Denise H, McNeil K, Brooks DR, Alexander J, Coombs GH, Mottram JC: Expression of multiple CPB genes encoding cysteine proteases is required for Leishmania mexicana virulence in vivo. Infect Immun 2003, 71(60):3190-3195.
10. Harth G, Andrews N, Mills AA, Engel JC, Smith R, McKerrow JH: Peptide- fluromethyl ketones arrest intracellular replication and intracellular transmission of Trypanosoma cruzi. Mol Biochem Parasitol 1993, 58:17-24.
11. Alexander J, Coombs GH, Mottram JC: Leishmania mexicana cysteine proteinase deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J Immunol 1998, 161:6794-6801.
12. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P: Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J Immunol 2003, 171(7):3711-3717.
13. McKerrow JH, McGrath ME, Engel JC: The cysteine protease of Trypanosoma cruzi as a model for antiparasitic drug design. Parasitol Today 1995, 11:279-282.
14. Rosenthal PJ, Kim K, McKerrow JH, Leech JH: Identification of three stage-specific proteinases from Plasmodium palcifarum. J Exp Med 1987, 166:816-821.
15. Maekawa Y, Himeno K, Ishikawa H, Hisaeda T, Sakai T, Dainichi T, Asao T, Good RA, Katunuma N: Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with Cathepsin B inhibitor in experimental leishmaniasis. J Immunol 1998, 161:2120-2127.
16. Zadeh-Vakili A, Taheri T, Doustdari F, Salmanian AH, Rafati S: Immunization with the hybrid protein vaccine consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis. Vaccine 2004, 22:1930-1940.
17. Omara-Opyene AL, Gedamu L: Molecular cloning, characterization and over expression of two distinct cysteine protease cDNA from Leishmania donovani chagasi. Mol Biochem Parasitol 1997, 90:247-267.
18. Mundodi V, Somanna A, Farrell P, Gedamu L: Genomic organization and functional expression of differentially regulated cysteine protease genes of Leishmania donovani complex. Gene 2002, 282:257-265.
19. Ankri S, Stolarsky T, Mirelman D: Antisense inhibition of expression of cysteine proteinases in Entamoeba histolytica does not affect cytopathic or hemolytic activity but inhibits phagocytosis. Mol Microbiol 1998, 28:777-785.
20. Ankri S, Stolarky T, Bracha R, Padilla-Vaca F, Mirelman D: Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica - induced formation of liver abscess in hamsters. Infect Immun 1999, 67:421-422.
21. Zhang WW, Matlashewski G: Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci U. S. A. 1997, 94:8807-8811.
22. Chen DQ, Kolli B, Yadav N, Lu HG, Sachs AG, Peterson DA, Chang KP: Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: Modulation of gp63 level in promastigotes and their infection of macrophage in vitro. Infect Immun 2000, 68:80-86.
23. Mottram JC, Robertson CD, Coombs GH, Barry JD: A developmentally regulated cysteine proteinase gene of Leishmania mexicana. Mol Microbiol 1992, 6:1925-1932.
24. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, Coombs GH: Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci U. S. A. 1996, 93:6008-6013.
25. Lasakosvitsch F, Gentil LG, dos Santos MRM, da Silveiri JF, Barbieri CL: Cloning and characterization of a Cysteine proteinase gene expressed in amastigotes of Leishmania (L.)amazonensis. Int J Parasitol 2003, 33:445-454.
26. Papadopoulou B, Roy G, Mourad W, Leblanc E, Quellette M: Changes in folate and pterin metabolism after disruption of the Leishmania H locus short-chain dehydrogenase gene. J Biol Chem 1994, 269:7310-7315.
27. Papadopoulou B, Roy G, Dey S, Rosen B, Olivier M, Quellette M: Gene disruption of the P-glycoprotein related gene pgpA of Leishmania tarentolae. Biochem Biophys Res Commun 1996, 224:772-778.
28. Kundig C, Leblanc E, Papadopoulou B, Ouellette M: Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae. Nucleic Acids Res 1999, 27:3653-3659.
29. Somanna A, Mundodi V, Gedamu L: In vitro cultivation and characterization of Leishmania chagasi amastigote-like forms. Acta Trop 2002, 83:37-42.
30. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LL, Leander KR, Martinez D, Perry HC, Shiver JW, Montogomery DL, Liu MA: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259:1745-1749.
31. Farrell PJ, Behie LA, Iatrou K: Secretion of cytoplasmic and nuclear proteins from animal cells using novel secretion modules. Prot Strut Fun Gen 2000, 41:144-153.
32. Farrell PJ, Lu M, Prevost J, Brown C, Behiw C, Iatrou K: High-level expression of secreted glycoproteins in transformed lepidopteran insect cells using a novel expression vector. Biotechnol Bioeng 1998, 60:6556-6563.
33. Streit JA, Donelson JE, Agey MW, Wilson ME: Developmental changes in the expression of Leishmania chagasi gp63 and heat shock protein in a human macrophage cell line. Infect Immun 1996, 64:1810-1818.